Pyrones as inhibitors of cyclooxygenase-2
    1.
    发明授权
    Pyrones as inhibitors of cyclooxygenase-2 失效
    Pyrones作为环加氧酶-2的抑制剂

    公开(公告)号:US06465509B2

    公开(公告)日:2002-10-15

    申请号:US09892941

    申请日:2001-06-27

    IPC分类号: A61K3135

    CPC分类号: C07D309/38

    摘要: The invention encompasses the novel compounds of Formula I, which are useful in the treatment of cyclooxygenase-2 mediated diseases. The invention also encompasses certain pharmaceutical compositions comprising compounds of Formula I as well as methods of treating cyclooxygenase-2 mediated diseases comprising administering to a patient in need of such treatment a non-toxic therapeutically effective amount of a compound of Formula I.

    摘要翻译: 本发明包括式I化合物,其可用于治疗环氧合酶-2介导的疾病。本发明还包括含有式I化合物的某些药物组合物以及治疗环加氧酶-2介导的疾病的方法,包括给予 需要这种治疗的患者是无毒的治疗有效量的式I化合物。

    NOVEL SPIRO COMPOUNDS USEFUL AS INHIBITORS OF STEAROYL-COENZYME A DELTA-9 DESATURASE
    8.
    发明申请
    NOVEL SPIRO COMPOUNDS USEFUL AS INHIBITORS OF STEAROYL-COENZYME A DELTA-9 DESATURASE 失效
    新型螺旋体化合物作为硬脂酸苄酯的一种抑制剂

    公开(公告)号:US20120122912A1

    公开(公告)日:2012-05-17

    申请号:US13383446

    申请日:2010-07-21

    CPC分类号: C07D491/107

    摘要: Heteroaromatic compounds of structural formula (I) are selective inhibitors of stearoyl-coenzyme A delta-9 desaturase (SCD1) relative to other known stearoyl-coenzyme A desaturases. The compounds of the present invention are useful for the prevention and treatment of conditions related to abnormal lipid synthesis and metabolism, including cardiovascular disease, such as atherosclerosis; obesity; diabetes; neurological disease; metabolic syndrome; insulin resistance; and liver steatosis.

    摘要翻译: 结构式(I)的杂芳族化合物是相对于其他已知的硬脂酰辅酶A去饱和酶的硬脂酰辅酶Aδ-9去饱和酶(SCD1)的选择性抑制剂。 本发明的化合物可用于预防和治疗与脂质合成和代谢异常有关的病症,包括心血管疾病,如动脉粥样硬化; 肥胖; 糖尿病; 神经系统疾病; 代谢综合征; 胰岛素抵抗; 和肝脂肪变性。